Home
Paul Peter Tak, CEO: Candel Therapeutics CADL Sell · Filed 24/12/03
Trade details
- Type
- Insider sale
- Amount
- $222,742.32
- Shares · price
- 48,847 sh · $4.56 a share
- Held after
- 294,788 sh
- Person
- Paul Peter TakCEO
- Trade date
- 24/11/29
- Filed
- 24/12/03
- Days to filing
- 4 days
Sold 14.2% of holdings
- Share of holding sold
- 14.2%
Candel Therapeutics trades, last 26 weeks
What else happened in Candel Therapeutics around then
Filed or reported within 30 days of the trade day · 24/10/30~24/12/29Paul Peter Tak's recent trades
- Paul Peter Tak
Planned sale10b5-1 planCandel Therapeutics
Planned sale10b5-1 planCandel Therapeutics
CADL
$3.4M
280,245 sh
$3.4M
Filed 09/10
Traded 09/10
- Paul Peter Tak
Sell10b5-1 planCandel Therapeutics
Sell10b5-1 planCandel Therapeutics
CADL
$226K
25,772 sh
$226K
Filed 25/03/20
Traded 25/03/18
- Paul Peter Tak
Sell10b5-1 planCandel Therapeutics
Sell10b5-1 planCandel Therapeutics
CADL
$3,600
400 sh
$3,600
Filed 25/03/20
Traded 25/03/19
- Paul Peter Tak
Planned sale10b5-1 planCandel Therapeutics
Planned sale10b5-1 planCandel Therapeutics
CADL
$654.4K
74,106 sh
$654.4K
Filed 25/03/18
Traded 25/03/18
- Paul Peter Tak
SellCandel Therapeutics
SellCandel Therapeutics
CADL
$156.9K
21,704 sh
$156.9K
Filed 25/01/17
Traded 25/01/15